MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 30 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,138,720 | -62.8% | 268,000 | -41.2% | 0.60% | -60.7% |
Q2 2023 | $105,336,000 | +8.4% | 456,000 | +13.7% | 1.52% | +9.0% |
Q1 2023 | $97,146,260 | +60.9% | 401,000 | +92.8% | 1.40% | +32.9% |
Q4 2022 | $60,372,000 | -24.8% | 208,000 | -83.2% | 1.05% | -24.4% |
Q3 2022 | $80,328,000 | +2.0% | 1,236,000 | +12.4% | 1.39% | +1.4% |
Q2 2022 | $78,738,000 | -17.9% | 1,100,000 | +12.5% | 1.37% | -26.0% |
Q1 2022 | $95,961,000 | +0.7% | 978,000 | -13.0% | 1.86% | +19.1% |
Q4 2021 | $95,248,000 | +15.2% | 1,124,000 | +8.5% | 1.56% | +11.4% |
Q3 2021 | $82,662,000 | +43.3% | 1,036,000 | +75.0% | 1.40% | +35.7% |
Q2 2021 | $57,667,000 | +40.9% | 592,000 | +69.1% | 1.03% | +9.8% |
Q1 2021 | $40,940,000 | +16.5% | 350,000 | +10.8% | 0.94% | -21.3% |
Q4 2020 | $35,130,000 | +6.4% | 316,000 | +13.7% | 1.20% | -0.2% |
Q3 2020 | $33,007,000 | +17.5% | 278,000 | +12.1% | 1.20% | -2.8% |
Q2 2020 | $28,086,000 | +94.8% | 248,000 | +14.8% | 1.23% | +38.1% |
Q1 2020 | $14,420,000 | -1.1% | 216,000 | +35.0% | 0.89% | +6.1% |
Q4 2019 | $14,578,000 | +56.6% | 160,000 | +48.1% | 0.84% | +36.3% |
Q3 2019 | $9,312,000 | -78.2% | 108,000 | -73.5% | 0.62% | -77.1% |
Q2 2019 | $42,762,000 | -19.7% | 408,000 | -4.0% | 2.70% | -7.5% |
Q1 2019 | $53,236,000 | +210.8% | 425,000 | +431.2% | 2.91% | +183.5% |
Q3 2018 | $17,130,000 | +43.8% | 80,000 | -21.6% | 1.03% | +12.8% |
Q1 2018 | $11,913,000 | +116.3% | 102,000 | +70.0% | 0.91% | +65.9% |
Q4 2017 | $5,507,000 | -42.3% | 60,000 | -71.7% | 0.55% | -51.1% |
Q3 2017 | $9,536,000 | +108.0% | 212,000 | -24.8% | 1.12% | +92.3% |
Q2 2017 | $4,585,000 | +132.6% | 282,000 | +120.3% | 0.58% | +43.5% |
Q1 2017 | $1,971,000 | +6.7% | 128,000 | +3.2% | 0.41% | -6.9% |
Q4 2016 | $1,848,000 | +10.4% | 124,000 | -6.1% | 0.44% | -18.6% |
Q3 2016 | $1,674,000 | – | 132,000 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |